The Oxford Academic Health Science Network gets innovation into clinical practice to improve patient safety, outcomes and experience, and generate economic growth through collaboration between the NHS, industry and universities. We cover a region of three million people living in Berkshire, Buckinghamshire, Milton Keynes and Oxfordshire. We aim to foster long term partnerships with industry, build a culture of innovation in the NHS, and have secured over £100 million of investment into the Thames Valley region. Our specialist capabilities include diagnostics and precision medicine, early innovator support and market access. You can find out more about how we can help on our website.
Find your nearest AHSN
The Oxford AHSN region has identified five local challenges; Increasing out-of-hospital care, redesigning and reducing pressure on hospital emergency services, offering more personalised care, digitally-enabled primary and outpatient care, improving outcomes by population health initiatives.
Oxford AHSN 2020 Accelerator Programme
The Oxford AHSN and BioCity launched the second year of the Oxford AHSN Accelerator Programme aimed at identifying and developing innovative and sustainable solutions to proven NHS needs and the commercial ambitions of investors
The Oxford Academic Health Science Network has extensive experience in real world evaluation projects, with the aim of gathering enough evidence to create a business case for these innovations.
AI technology speeds up stroke care and reduces costs
New artificial intelligence (AI)-driven imaging support software which has the potential to deliver huge benefits to hundreds of stroke patients each year and significant cost savings to the NHS has been implemented at the Royal Berkshire NHS Foundation Trust (RBH). The Oxford AHSN is supporting wider regional roll-out backed by NHS England. The CE-marked e-Stroke Suite developed by Brainomix Ltd includes tools for non-contrast CT and CT angiography brain scans, connecting physicians and facilitating information transfer. The software supports physicians in identifying patients who would benefit from acute stroke treatments, selecting patients most likely to benefit from specific interventions, such as mechanical thrombectomy.
Can using point of care blood tests help inform decision making in patients over 65 presenting with acute frailty syndrome?
UK ambulance services have been identified as potential beneficiaries of point of care testing (POCT) to guide patient management and care pathways, but there is little published evidence on the uses, benefits and health economics of POCT in pre-hospital settings. The Oxford AHSN, along with eight specialist paramedics based at the Royal Berkshire Hospital in Reading, conducted a quality improvement study to look at utilising POCT to aid decision-making in patients aged over 65 presenting to South Central Ambulance Service with acute frailty syndrome.
Oxford AHSN supports NHS response to Covid-19 with new innovations
With our partners across the NHS and social care now mobilising at scale in response to the developi...